美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Columbia Research Enhanced Value ETF

34.13

+0.12390.36%

成交量：2.74萬

成交額：93.26萬

市值：3.48億

市盈率：- -

高：34.17

開：34.17

低：34.03

收：34.00

52周最高：34.23

52周最低：27.24

股本：1,021.04萬

流通股本：1,021.04萬

量比：1.09

換手率：0.27%

股息：0.60

股息率：1.76%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

美銀一口氣上調10只軟件股目標價！Workday(WDAY.US)飆漲46%領銜，AI擔憂退潮估值修復提速

澳大利亞儲備銀行：但當前政策的限制性程度已足以在合理時間框架內將通脹回落至目標水平。

【券商聚焦】國泰海通維持保險業「增持」評級《資產負債管理辦法》支撐板塊估值修復

【券商聚焦】交銀國際維持先聲藥業（02096）買入評級指新品集中上市及全球化提速支撐估值修復

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/REVS"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVS\",,,,,undefined,":{"symbol":"REVS","market":"US","secType":"STK","nameCN":"Columbia Research Enhanced Value ETF","latestPrice":34.1284,"timestamp":1787601600000,"preClose":34.0045,"halted":0,"volume":27357,"delay":0,"changeRate":0.0036436354011968714,"floatShares":10210364,"shares":10210364,"eps":0,"marketStatus":"盤前交易","change":0.1239,"latestTime":"08-25 06:42:35 EDT","open":34.17,"high":34.17,"low":34.03,"amount":932629.046349,"amplitude":0.004117,"askPrice":38.75,"askSize":100,"bidPrice":29.87,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":34.1284,"sharesOutstanding":7400000,"nav":33.96295,"aum":348472229.56,"dividendRate":0.017601,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.11,"preClose":34.1284,"latestTime":"19:30 EDT","volume":10,"amount":341.284,"timestamp":1787614206860,"change":-0.0184,"changeRate":-0.000539,"amplitude":0},"volumeRatio":1.0857762072594017},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVS\",,,,,undefined,":{"symbol":"REVS","floatShares":10210364,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0857762072594017,"shares":10210364,"dividePrice":0.6007,"high":34.17,"amplitude":0.004117,"preClose":34.0045,"low":34.03,"week52Low":27.2428,"pbRate":"--","week52High":34.2294,"institutionHeld":0,"latestPrice":34.1284,"eps":0,"divideRate":0.017601,"volume":27357,"delay":0,"ttmEps":0,"open":34.17,"prevYearClose":28.283,"prevWeekClose":34.0045,"prevMonthClose":33.2,"prevQuarterClose":31.44,"fiveDayClose":33.7438,"twentyDayClose":33.04,"sixtyDayClose":31.5159},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REVS\",params:#limit:5,,,undefined,":[{"date":"2025-12-18","symbol":"REVS","amount":0.60215,"announcedDate":"2025-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-18","defaultRemindTime":1766068200000,"name":"Columbia Research Enhanced Value ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-18","currency":"USD","dateTimestamp":1766034000000,"payDate":"2025-12-26"},{"date":"2024-12-18","symbol":"REVS","amount":0.46667,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-18","defaultRemindTime":1734532200000,"name":"Columbia Research Enhanced Value ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-18","currency":"USD","dateTimestamp":1734498000000,"payDate":"2024-12-26"},{"date":"2023-12-18","symbol":"REVS","amount":0.53855,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"Columbia Research Enhanced Value ETF","recordDate":"2023-12-26","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-26"},{"market":"US","date":"2022-12-19","symbol":"REVS","amount":0.48105,"defaultRemindTime":1671460200000,"name":"Columbia Research Enhanced Value ETF","recordDate":"2022-12-27","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"REVS","amount":0.12796,"defaultRemindTime":1640010600000,"name":"Columbia Research Enhanced Value ETF","recordDate":"2021-12-28","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REVS\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-20","recordDate":"2019-12-23","paymentDate":"2019-12-26","value":0.00358,"currency":"USD"},{"executeDate":"2020-12-18","recordDate":"2020-12-21","paymentDate":"2020-12-28","value":0.49625,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-28","value":0.12796,"currency":"USD"},{"executeDate":"2022-12-19","recordDate":"2022-12-20","paymentDate":"2022-12-27","value":0.48105,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-26","value":0.53855,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REVS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REVS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662878182","title":"美銀一口氣上調10只軟件股目標價！Workday(WDAY.US)飆漲46%領銜，AI擔憂退潮估值修復提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2662878182","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662878182?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 14:53","pubTimestamp":1787640833,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGIX","LCO","IGM","LU0719512351.SGD","WDAY","CHAT","LU0082616367.USD","LU1935043536.SGD","REVS","VTHR","LU1823568750.SGD","BK4581","BK4613","LU1046421795.USD","LU2265009873.SGD","AIPO","IGV","CZA","LU1989763005.USD","LU1935042991.SGD","LU2517655291.USD","LU2517655028.SGD","BK4548","ARTY","BK4023","BK4585","LU1804176565.USD","LU2517655374.HKD","BK4588","QTOC","IE0004445239.USD","NIFE","LU0314104364.USD","LU1691799644.USD","IE0009356076.USD","BK4528","LU1989773731.SGD","LU1235294995.USD","IE00B5949003.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207421","title":"澳大利亞儲備銀行：但當前政策的限制性程度已足以在合理時間框架內將通脹回落至目標水平。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207421","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207421?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:31","pubTimestamp":1787621493,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MAVF","DSTL","MOAT","LQ","BGDV","RSP","HFSI","AOM","BLCV","LVHD","NDOW","RPHS","AGOX","RWVG","SQLV","OBND","MCOW","OCIO","SPDG","FOVL","SMRI","EZRO","BINC","GVUS","FVAL","MFUL","EASY","PY","QARP","BBHM","WBND","ABEQ","DVY","ULVM","VLU","PJFV","DUKZ","THRV","DURA","QPX","EUCG","REVS","HDV","USDX","RDVY","CAMX","XFLX","OACP","CGCV","DFLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207403","title":"【券商聚焦】國泰海通維持保險業「增持」評級 《資產負債管理辦法》支撐板塊估值修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207403","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207403?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:29","pubTimestamp":1787621380,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券研究指，8月21日，金监总局发布《保险公司资产负债管理办法》（下称《办法》），于27年1月1日实施，不达标险企设置三年过渡期。该机构认为，当前保险股PEV估值仍反映较为悲观的投资收益率预期，核心原因在于资负错配导致ROE的不确定性较高。该机构预计《资产负债管理办法》将由治理体系到经营层面深刻影响险企保险业务发展及资产配置行为，有效的资产负债匹配管理利好保险公司的盈利稳定性提升，从而对估值修复构成有效支撑，维持“增持”评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989229","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GABF","REVS","02611","KCE","NIFE","FXO","LCO","CZA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207163","title":"【券商聚焦】交銀國際維持先聲藥業（02096）買入評級 指新品集中上市及全球化提速支撐估值修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207163","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207163?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:23","pubTimestamp":1787620993,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，先声药业 1H26收入和经调整净利润分别增长27.8%/48.7%，其中创新药收入+34%至39亿元，对总收入的贡献升至85%。3）自免线艾得辛虽未中标集采，但公司目标维持约50%市场份额。IL-4R和外用JAK1/JAK2凝胶预计2027 年商业化，缓解艾得辛竞争压力。公司维持全年收入100亿元的指引，经调整净利润指引从16亿上调至18亿元。该机构将DCF模型向前滚动至2027 年，得到最新目标价20港元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989224","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","REVS","NIFE","KCE","IPOS","LCO","CZA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":48,"pageCount":1,"totalSize":190,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/REVS\",params:#limit:6,delay:false,,,undefined,":[]}}